These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 8634959

  • 1. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
    Dickens BM, Pei N, Taylor KM.
    CMAJ; 1996 Mar 15; 154(6):813-8. PubMed ID: 8634959
    [Abstract] [Full Text] [Related]

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology.
    J Clin Oncol; 2003 Jun 15; 21(12):2397-406. PubMed ID: 12692171
    [Abstract] [Full Text] [Related]

  • 3. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.
    Macdonald KG, Doan B, Kelner M, Taylor KM.
    CMAJ; 1996 Feb 15; 154(4):457-64. PubMed ID: 8630835
    [Abstract] [Full Text] [Related]

  • 4. The genetic testing of children for cancer susceptibility: ethical, legal, and social issues.
    Patenaude AF.
    Behav Sci Law; 1996 Feb 15; 14(4):393-410. PubMed ID: 9156420
    [Abstract] [Full Text] [Related]

  • 5. The emerging role of the physician in genetic counselling and testing for heritable breast, ovarian and colon cancer.
    Taylor KM, Kelner MJ.
    CMAJ; 1996 Apr 15; 154(8):1155-8. PubMed ID: 8612250
    [Abstract] [Full Text] [Related]

  • 6. Bioethics for clinicians: 14. Ethics and genetics in medicine.
    Burgess MM, Laberge CM, Knoppers BM.
    CMAJ; 1998 May 19; 158(10):1309-13. PubMed ID: 9614824
    [Abstract] [Full Text] [Related]

  • 7. Professional challenges in cancer genetic testing: who is the patient?
    Chan-Smutko G, Patel D, Shannon KM, Ryan PD.
    Oncologist; 2008 Mar 19; 13(3):232-8. PubMed ID: 18378533
    [Abstract] [Full Text] [Related]

  • 8. Ethical and scientific considerations for chemoprevention research in cohorts at genetic risk for breast cancer.
    Nayfield SG.
    J Cell Biochem Suppl; 1996 Mar 19; 25():123-30. PubMed ID: 9027608
    [Abstract] [Full Text] [Related]

  • 9. Notification of a family history of breast cancer: issues of privacy and confidentiality.
    Winter PR, Wiesner GL, Finnegan J, Bartels D, LeRoy B, Chen PL, Sellers TA.
    Am J Med Genet; 1996 Dec 02; 66(1):1-6. PubMed ID: 8957501
    [Abstract] [Full Text] [Related]

  • 10. Breast cancer, the genetic "quick fix," and the Jewish community. Ethical, legal, and social challenges.
    Rothenberg KH.
    Health Matrix Clevel; 1997 Dec 02; 7(1):97-124. PubMed ID: 10167180
    [No Abstract] [Full Text] [Related]

  • 11. Controversies and ethical issues in cancer-genetics clinics.
    Harris M, Winship I, Spriggs M.
    Lancet Oncol; 2005 May 02; 6(5):301-10. PubMed ID: 15863378
    [Abstract] [Full Text] [Related]

  • 12. "Decoding" informed consent. Insights from women regarding breast cancer susceptibility testing.
    Geller G, Strauss M, Bernhardt BA, Holtzman NA.
    Hastings Cent Rep; 1997 May 02; 27(2):28-33. PubMed ID: 9131350
    [Abstract] [Full Text] [Related]

  • 13. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B.
    Cancer Epidemiol Biomarkers Prev; 2000 Nov 02; 9(11):1251-4. PubMed ID: 11097234
    [Abstract] [Full Text] [Related]

  • 14. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D, Runowicz CD.
    Curr Womens Health Rep; 2002 Jun 02; 2(3):163-9. PubMed ID: 12099190
    [Abstract] [Full Text] [Related]

  • 15. [The origin of informed consent].
    Mallardi V.
    Acta Otorhinolaryngol Ital; 2005 Oct 02; 25(5):312-27. PubMed ID: 16602332
    [Abstract] [Full Text] [Related]

  • 16. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.
    Shah MR.
    Mo Med; 2004 Oct 02; 101(2):105-10; quiz 110-1. PubMed ID: 15119107
    [Abstract] [Full Text] [Related]

  • 17. The "new" genetics: emerging medicolegal issues in the prenatal issues in the prenatal diagnosis of hereditary disorders.
    Milunsky A, Reilly P.
    Am J Law Med; 1975 Mar 02; 1(1):71-88. PubMed ID: 1234716
    [Abstract] [Full Text] [Related]

  • 18. Ethical and legal aspects of cancer genetic testing.
    Offit K, Thom P.
    Semin Oncol; 2007 Oct 02; 34(5):435-43. PubMed ID: 17920900
    [Abstract] [Full Text] [Related]

  • 19. Testing for genetic traits: the need for a new legal doctrine of informed consent.
    Cooper EB.
    MD Law Rev; 1999 Oct 02; 58(2):346-422. PubMed ID: 11660778
    [No Abstract] [Full Text] [Related]

  • 20. Duty to disclose in medical genetics: a legal perspective.
    Pelias MZ.
    Am J Med Genet; 1991 Jun 01; 39(3):347-54. PubMed ID: 1867289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.